New COVID-19 Variant “FLiRT” Takes Hold in U.S., CDC Warns of Dangerous Symptoms

Atlanta, Georgia – A new set of COVID-19 variants is making its presence known in the United States, as reported by the Centers for Disease Control and Prevention (CDC). This cluster of variants, known as “FLiRT,” has emerged as the dominant strain across the country. Among these variants, the KP.2 strain, a subtype of FLiRT, accounts for approximately 25% of current infections in the U.S.

According to health experts, the KP.2 variant of the FLiRT cluster could pose a greater threat than previous strains of COVID-19. Megan L. Ranney, MD, the Dean of the Yale School of Public Health, highlighted concerning characteristics of FLiRT, such as mutations in the spike protein that can enhance the virus’s ability to infect individuals.

Despite a decline in severe cases, the CDC stresses that COVID-19 remains a significant public health concern. In response to the evolving situation, it is recommended that individuals aged 65 and older receive an additional dose of the updated COVID-19 vaccine to enhance protection.

As the FLiRT variants continue to circulate, understanding the symptoms associated with these strains is crucial for early detection and management. Symptoms of the FLiRT variants may include a sore throat, cough, fatigue, congestion, runny nose, headache, muscle aches, fever or chills, loss of taste or smell, shortness of breath, nausea, vomiting, and diarrhea.

In light of these developments, public health officials emphasize the importance of staying informed, practicing preventive measures, and seeking medical attention promptly if symptoms arise. The emergence of new variants underscores the ongoing need for vigilance and proactive measures to combat the spread of COVID-19 in communities across the United States.